Honasa acquires 58% of Fluence Pharma, bets on Nutraceuticals push

Honasa Consumer, the parent company of Mamaearth, has acquired a 58% stake in Mumbai-based Fluence Pharma Private Limited at an enterprise value of approximately Rs 135 crore. The board approved the deal on June 23, 2026, and disclosed it to the BSE and NSE the same evening under Regulation 30 of SEBI’s Listing Obligations. The transaction is expected to close within eight weeks of board approval.